Mpm Bioimpact LLC Top Holdings and 13F Report (2024)

→ A Silent Invasion of America (From The Freeport Society) (Ad)

About Mpm Bioimpact LLC

Investment Activity

Mpm Bioimpact LLC has $621.98 million in total holdings as of March 31, 2024.
Mpm Bioimpact LLC owns shares of 38 different stocks, but just 22 companies or ETFs make up 80% of its holdings.
Approximately 25.95% of the portfolio was purchased this quarter.
About 12.49% of the portfolio was sold this quarter.
This quarter, Mpm Bioimpact LLC has purchased 32 new stocks and bought additional shares in 14 stocks.
Mpm Bioimpact LLC sold shares of 4 stocks and completely divested from 6 stocks this quarter.

Largest Holdings

Cullinan Therapeutics: $130,326,487
Geron: $34,569,728
Iovance Biotherapeutics: $32,604,000
Zentalis Pharmaceuticals: $23,895,044
iTeos Therapeutics: $23,814,663

Largest New Holdings this Quarter

Zentalis Pharmaceuticals: $23,895,044 Holding
Sutro Biopharma: $23,145,897 Holding
Natera: $15,768,893 Holding
Ultragenyx Pharmaceutical: $11,466,597 Holding
89bio: $11,264,517 Holding

Largest Purchases this Quarter

Zentalis Pharmaceuticals: 1,516,183 shares (about $23.90M)
Sutro Biopharma: 4,096,619 shares (about $23.15M)
Natera: 172,413 shares (about $15.77M)
Ultragenyx Pharmaceutical: 245,590 shares (about $11.47M)
89bio: 967,742 shares (about $11.26M)

Largest Sales this Quarter

Iovance Biotherapeutics: 1,089,470 shares (about $16.15M)
Viking Therapeutics: 175,284 shares (about $14.37M)
Geron: 239,945 shares (about $791.82K)
Revolution Medicines: 191 shares (about $6.16K)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
CGEM Cullinan Therapeutics	$130,326,487		0.0%	7,648,268	21.0%	Medical
GERN Geron	$34,569,728	$791,819 ▼	-2.2%	10,475,675	5.6%	Medical
IOVA Iovance Biotherapeutics	$32,604,000	$16,145,945 ▼	-33.1%	2,200,000	5.2%	Medical
ZNTL Zentalis Pharmaceuticals	$23,895,044	$23,895,044 ▲	New Holding	1,516,183	3.8%	Medical
ITOS iTeos Therapeutics	$23,814,663		0.0%	1,745,943	3.8%	Medical
STRO Sutro Biopharma	$23,145,897	$23,145,897 ▲	New Holding	4,096,619	3.7%	Medical
CRNX Crinetics Pharmaceuticals	$22,496,324	$110,191 ▲	0.5%	480,588	3.6%	Medical
OLMA Olema Pharmaceuticals	$22,115,771	$1,092,991 ▲	5.2%	1,953,690	3.6%	Medical
MDGL Madrigal Pharmaceuticals	$16,395,989	$5,471,383 ▲	50.1%	61,399	2.6%	Medical
NTRA Natera	$15,768,893	$15,768,893 ▲	New Holding	172,413	2.5%	Medical
HOWL Werewolf Therapeutics	$15,474,311		0.0%	2,388,011	2.5%	Medical
MLTX MoonLake Immunotherapeutics	$14,870,592	$74,039 ▲	0.5%	296,050	2.4%	Medical
AVDL Avadel Pharmaceuticals	$14,713,707	$3,482,093 ▲	31.0%	871,149	2.4%	Medical
INSM Insmed	$14,400,441	$71,732 ▲	0.5%	530,794	2.3%	Medical
ALXO ALX Oncology	$14,143,452	$41,389 ▲	0.3%	1,268,471	2.3%	Medical
VKTX Viking Therapeutics	$12,300,000	$14,373,288 ▼	-53.9%	150,000	2.0%	Medical
NTLA Intellia Therapeutics	$11,900,771	$1,375,500 ▲	13.1%	432,598	1.9%	Medical
RGNX REGENXBIO	$11,569,073		0.0%	549,078	1.9%	Medical
RARE Ultragenyx Pharmaceutical	$11,466,597	$11,466,597 ▲	New Holding	245,590	1.8%	Medical
MORF Morphic	$11,451,722	$56,003 ▲	0.5%	325,333	1.8%	Medical
ETNB 89bio	$11,264,517	$11,264,517 ▲	New Holding	967,742	1.8%	Medical
VRDN Viridian Therapeutics	$10,751,315	$9,000,315 ▲	514.0%	614,010	1.7%	Medical
FULC Fulcrum Therapeutics	$10,734,300	$10,734,300 ▲	New Holding	1,137,108	1.7%	Medical
XERS Xeris Biopharma	$9,207,956	$705,573 ▲	8.3%	4,166,496	1.5%	Medical
AXSM Axsome Therapeutics	$9,107,335	$1,655,052 ▲	22.2%	114,127	1.5%	Medical
KALV KalVista Pharmaceuticals	$9,022,163	$9,022,163 ▲	New Holding	760,722	1.5%	Medical
RVMD Revolution Medicines	$8,805,784	$6,156 ▼	-0.1%	273,217	1.4%	Medical
VERV Verve Therapeutics	$8,474,805		0.0%	638,163	1.4%	Medical
FOLD Amicus Therapeutics	$8,469,467	$36,365 ▲	0.4%	718,970	1.4%	Medical
AKRO Akero Therapeutics	$8,409,660	$8,409,660 ▲	New Holding	332,924	1.4%	Medical
ADAP Adaptimmune Therapeutics	$8,051,541		0.0%	5,095,912	1.3%	Medical
EWTX Edgewise Therapeutics	$8,048,564	$8,048,564 ▲	New Holding	441,259	1.3%	Medical
RPTX Repare Therapeutics	$7,723,689		0.0%	1,639,849	1.2%	Medical
RLAY Relay Therapeutics	$6,905,741		0.0%	832,017	1.1%	Medical
IRON Disc Medicine	$6,897,101	$3,784,101 ▲	121.6%	110,779	1.1%	Medical
TRVI Trevi Therapeutics	$4,626,312	$4,626,312 ▲	New Holding	1,340,960	0.7%	Medical
Immatics NV	$4,153,941	$4,153,941 ▲	New Holding	395,237	0.7%	Common
CMPX Compass Therapeutics	$3,903,376	$3,903,376 ▲	New Holding	1,971,402	0.6%	Medical
KRTX Karuna Therapeutics	$0	$16,863,336 ▼	-100.0%	0	0.0%	Medical
CBAY CymaBay Therapeutics	$0	$14,436,095 ▼	-100.0%	0	0.0%	Medical
GPCR Structure Therapeutics	$0	$9,403,169 ▼	-100.0%	0	0.0%	Medical
Harpoon Therapeutics, Inc.	$0	$3,634,648 ▼	-100.0%	0	0.0%	Common
INZY Inozyme Pharma	$0	$1,379,443 ▼	-100.0%	0	0.0%	Medical
PHAT Phathom Pharmaceuticals	$0	$639,100 ▼	-100.0%	0	0.0%	Medical